The startup, which leverages technology to assist chronic kidney disease and end-stage renal disease patients, has wrapped up a $24 million Series A round led by Oak HC/FT.
The bill, known as the ESRD Choice Act (H.R. 5?659), would allow enrollment in the Medicare managed care plans to ESRD patients undergoing dialysis treatment.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Investment driven from Baxter Ventures and Boston Scientific Corporation has brought TVA Medical up by $15 million.